Kepler Capital Markets Reiterates “Buy” Rating for Benchmark (BMK)
Benchmark (LON:BMK)‘s stock had its “buy” rating restated by investment analysts at Kepler Capital Markets in a report released on Monday.
BMK opened at GBX 60.50 ($0.79) on Monday. Benchmark has a 1-year low of GBX 36 ($0.47) and a 1-year high of GBX 99.80 ($1.30).
In other Benchmark news, insider Hugo Wahnish acquired 100,000 shares of the stock in a transaction on Tuesday, October 9th. The shares were purchased at an average price of GBX 57 ($0.74) per share, for a total transaction of £57,000 ($74,480.60).
Benchmark Holdings plc provides technical services, products, and specialist knowledge for the development of food and farming industries worldwide. It operates through Animal Health, Breeding and Genetics, Advanced Animal Nutrition, Sustainability Science, and Technical Publishing divisions. The Animal Health division manufactures licensed vaccines and antigens for farm, aquatic, and companion animals, as well as engages in the contract manufacturing of veterinary vaccines.
Featured Article: What does relative strength index mean?
Receive News & Ratings for Benchmark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Benchmark and related companies with MarketBeat.com's FREE daily email newsletter.